CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS

Aim. Hospital-based economic analysis for the use of thrombopoietin receptor agonists (TRA) Eltrombopag and Romiplostim has been performed in patients with chronic idiopathic thrombocytopenic purpura (ITP) at the background failure of previous treatment options. Materials and methods. Two models for...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva
Formatua: Artigo
Hizkuntza:Russo
Argitaratua: IRBIS LLC 2016-02-01
Saila:Фармакоэкономика
Gaiak:
idiopathic thrombocytopenic purpura (itp)
cost-minimization analysis
budget impact analysis
thrombopoietin receptor agonist (tpo-ra)
eltrombopag
romiplostim
Sarrera elektronikoa:https://www.pharmacoeconomics.ru/jour/article/view/130
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak